文献速递肾移植肾血管病与高血压

炎症状态是肾移植心血管疾病与移植物纤维化的危险因素

The inflammatory state is a risk factor for cardiovascular disease and graft fibrosis in kidney transplantation.
PubMed 文献 · Kidney Int · 2021-04-28

综述指出肾移植中多种因素诱导炎症状态,炎症与血栓形成交互增加心血管病风险,并通过白细胞介素1和6、血管紧张素II及转化生长因子β导致间质纤维化和慢性移植物功能障碍;生活方式和运动可能减轻炎症,多种药物被提出但尚无前瞻性对照试验。

要点

  • 炎症状态与血栓形成交互,增加肾移植受者心血管病风险。
  • 炎症通过IL-1、IL-6、AngII和TGF-β促进间质纤维化和移植物功能障碍。
  • 低剂量阿司匹林、他汀等药物被提出控制炎症,但缺乏前瞻性对照试验证据。

核心结论

  • 炎症状态是肾移植受者心血管疾病和移植物纤维化的危险因素。

研究设计与样本

  • 综述,未报告系统检索范围与样本量。

主要发现

  • 供体脑死亡、缺血再灌注损伤、排斥、感染和慢性移植物功能障碍可诱导炎症状态。
  • 炎症与血栓形成交互导致促血栓状态和纤溶受损,增加心血管病风险。
  • 炎症与成纤维细胞生长因子23升高和Klotho降低相关,促进主要不良心血管事件。
  • 高尿酸血症、糖耐量异常、动脉高血压、血脂异常和缺乏运动形成metaflammation参与动脉粥样硬化。
  • 炎症通过IL-1、IL-6、AngII和TGF-β介导慢性缺氧,导致细胞外基质过度积累和间质纤维化。

临床怎么用

  • 生活方式和规律体力活动可能减轻炎症。
  • 低剂量阿司匹林、他汀、肾素-血管紧张素抑制剂、黄嘌呤氧化酶抑制剂、维生素D补充和IL-6阻断被提出用于控制移植物炎症状态。
  • 上述措施尚无前瞻性对照试验在肾移植中验证。

局限性

  • 无前瞻性对照试验验证所述药物在肾移植中的疗效。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Several factors, such as donor brain death, ischemia-reperfusion injury, rejection, infection, and chronic allograft dysfunction, may induce an inflammatory state in kidney transplantation. Furthermore, inflammatory cells, cytokines, growth factors, complement and coagulation cascade create an unbalanced interaction with innate and adaptive immunity, which are both heavily involved in atherogenesis. The crosstalk between inflammation and thrombosis may lead to a prothrombotic state and impaired fibrinolysis in kidney transplant recipients increasing the risk of cardiovascular disease. Inflammation is also associated with elevated levels of fibroblast growth factor 23 and low levels of Klotho, which contribute to major adverse cardiovascular events. Hyperuricemia, glucose intolerance, arterial hypertension, dyslipidemia, and physical inactivity may create a condition called metaflammation that concurs in atherogenesis. Another major consequence of the inflammatory state is the development of chronic hypoxia that through the mediation of interleukins 1 and 6, angiotensin II, and transforming growth factor beta can result in excessive accumulation of extracellular matrix, which can disrupt and replace functional parenchyma, leading to interstitial fibrosis and chronic allograft dysfunction. Lifestyle and regular physical activity may reduce inflammation. Several drugs have been proposed to control the graft inflammatory state, including low-dose aspirin, statins, renin-angiotensin inhibitors, xanthine-oxidase inhibitors, vitamin D supplements, and interleukin-6 blockade. However, no prospective controlled trial with these measures has been conducted in kidney transplantation.

来源:Kidney Int,查看原文。版权归原作者所有。

引用

  1. Ponticelli C, Campise MR. The inflammatory state is a risk factor for cardiovascular disease and graft fibrosis in kidney transplantation. Kidney Int. 2021. PMID: 33932457. doi:10.1016/j.kint.2021.04.016

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。